Media Reports Suggest Generic Drug Manufacturers Could Face Collusion Charges
Media reports suggest that charges may be filed by the U.S. Department of Justice against a number of generic-drug manufacturers over price collusion. We have been aware of the investigation, for which many manufacturers have previously disclosed receiving subpoenas, but we have little concrete information into the specific drugs and companies and each company's respective exposure, not to mention if actual evidence of price collusion exists and if charges will officially be brought. We have see...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.